Increased activation of the epidermal growth factor receptor in transgenic mice overexpressing epigen causes peripheral neuropathy  by Dahlhoff, Maik et al.
Biochimica et Biophysica Acta 1832 (2013) 2068–2076
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isIncreased activation of the epidermal growth factor receptor in
transgenic mice overexpressing epigen causes peripheral neuropathyMaik Dahlhoff a,⁎, Daniela Emrich b, Eckhard Wolf a, Marlon R. Schneider a
a Institute of Molecular Animal Breeding and Biotechnology, Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, 81377 Munich, Germany
b Institute of Veterinary Pathology, Center for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany⁎ Corresponding author at: Gene Center, LMU Munic
Munich, Germany. Tel.: +49 89218076815.
E-mail address: dahlhoff@lmb.uni-muenchen.de (M. D
0925-4439/$ – see front matter © 2013 Elsevier B.V. All r
http://dx.doi.org/10.1016/j.bbadis.2013.07.011a b s t r a c ta r t i c l e i n f oArticle history:
Received 7 March 2013
Received in revised form 17 June 2013
Accepted 22 July 2013
Available online 27 July 2013
Keywords:
Epigen
EGFR
Mouse model
Demyelination
Axon degenerationIn the mammalian nervous system, axons are commonly surrounded bymyelin, a lipid-rich sheath that is essen-
tial for precise and rapid conduction of nerve impulses. In the peripheral nervous system (PNS), myelin sheaths
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epidermal growth factor receptor (EGFR) in the regulation of PNS myelination. Here, we report a peripheral
neurodegenerative disease caused by increased EGFR activation. Speciﬁcally, we characterize a symmetric and
distally pronounced, late-onset muscular atrophy in transgenic mice overexpressing the EGFR ligand epigen.
Histological examination revealed a demyelinating neuropathy and axon degeneration, and molecular analysis
of signaling pathways showed reduced protein kinase B (PKB, AKT) activation in the nerves of Epigen-tg mice,
indicating that the muscular phenotype is secondary to PNS demyelination and axon degeneration. Crossing of
Epigen-tg mice into an EGFR-deﬁcient background revealed the pathology to be completely EGFR-dependent.
This mouse line provides a new model for studying molecular events associated with early stages of peripheral
neuropathies, an essential prerequisite for the development of successful therapeutic interventions.
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In themammalian nervous system, axons are frequently surrounded
bymyelin, a lipid-rich sheath that is essential for precise and rapid con-
duction of nerve impulses and for protection against axonal damage.
Myelin sheath formation and maintenance underlies a complex signal-
ing crosstalk between axons and oligodendrocytes (in the central
nervous system, CNS) or axons and Schwann cells (in the peripheral
nervous system, PNS) [1]. In both cases, the myelinating cell wraps a
specialized plasmamembranemultiple times around the axon. Notably,
the number of wraps (and consequently the myelin thickness) is
proportional to the axon diameter, highlighting the strong interaction
between the two cell types [2]. Precise myelination is a critical process,
and its deregulation results in numerous severe neurological diseases,
including multiple sclerosis and peripheral neuropathies.
Over the recent years, much has been learned about the speciﬁc
signaling pathways regulating Schwann cell development and the
maintenance ofmyelin sheaths in the PNS throughout life [3–5]. A num-
ber of studies, based mainly on the phenotypes of genetically modiﬁed
mouse models, revealed that neuregulin-1 (NRG1) provides a key
axonal signal that regulates Schwann cell proliferation, migration, and
myelination (reviewed in [6]). For example, reduced NRG1 expressionh, Feodor-Lynen-Str. 25, 81377
ahlhoff).
ights reserved.causes hypomyelination and decreases nerve conduction velocity,
while neuronal overexpression of NRG1 induces hypermyelination [7].
NRG1 effects are mediated by Schwann cell-based ERBB2/3 receptor
tyrosine kinases, whose loss causes severe defects in early Schwann
cell development [8,9]. These receptors belong to the broad EGFR/
ERBB signaling pathway, which exertsmultiple actions in development,
tissue homeostasis, and disease [10,11].
The epidermal growth factor receptor (EGFR) has been implicated in
themyelination of the central nervous system [12] and in the expansion
of peripheral nervous system progenitor cells, including Schwann cell
precursors [13]. However, in contrast to ERBB2/3, the EGFR is not
considered a major player in the myelination process. In this study,
we report a symmetric and distally pronounced, late-onset muscular
atrophy in transgenic mice overexpressing the EGFR ligand epigen.
The neuropathy is secondary to PNS demyelination and axon degenera-
tion, and is fully EGFR-dependent.
2. Materials and methods
2.1. Animal models
The generation of Epigen-tgmice has been described in detail previ-
ously [14]. EgfrWa5/+ mice (Wa5) expressing an antimorphic Egfr allele
[15] were donated by the Medical Research Council (Oxfordshire, UK)
via Dr. David Threadgill (University of North Carolina, NC, USA). All
experiments were done with mice from both genders in the C57BL/6N
Table 1
Sequences of the primers and probes employed for the quantitative RT-PCR analysis.
Actb Forward primer
Reverse primer
Fluorogenic probe
5′-CGTGAAAAGATGACCCAGATCA-3′
5′-CACAGCCTGGATGGCTACGT-3′
5′-TTTGAGACCTTCAACACCCCAGCCA-3′
Mbp Forward primer
Reverse primer
Fluorogenic probe
5′-ATCCAAGTACCTGGCCACAG-3′
5′-CAAGGATGCCCGTGTCTC-3′
5′-CTTCCTCC-3′
Mpz Forward primer
Reverse primer
Fluorogenic probe
5′-TTTGAAAAAGTGCCCACTAGGT-3′
5′-AAGAGCAACAGCAGCAACAG-3′
5′-GGGAGCAG-3′
Gjb1 Forward primer
Reverse primer
Fluorogenic probe
5′-GATGAGAAGTCCTCTTTCATCTGTAAC-3′
5′-GGTCATAGCAGACGCTGTTG-3′
5′-CTCCAGCC-3′
Table 2
Antibodies employed for Western blot analysis and their dilutions.
Antigen Antibody Host Dilution
EGFR Santa Cruz, Heidelberg, Germany #sc-03 Rabbit 1:500
p-TYR Cell Signaling, Frankfurt, Germany #9411 Mouse 1:2000
p-AKT1 Cell Signaling, Frankfurt, Germany #4060 Rabbit 1:2000
AKT1 Cell Signaling, Frankfurt, Germany #4691 Rabbit 1:2000
p-MAPK1/2 Cell Signaling, Frankfurt, Germany #4370 Rabbit 1:2000
MAPK1/2 Cell Signaling, Frankfurt, Germany #9102 Rabbit 1:2000
p-KPCA Cell Signaling, Frankfurt, Germany #9375 Rabbit 1:2000
KPCΑ Cell Signaling, Frankfurt, Germany #2056 Rabbit 1:2000
CADH1 BD, Heidelberg, Germany #610182 Mouse 1.2500
CADH2 Cell Signaling, Frankfurt, Germany #4061 Rabbit 1:2000
CTNB1 BD, Heidelberg, Germany #610154 Mouse 1:2500
p-MKD8/9 Cell Signaling, Frankfurt, Germany #9251 Rabbit 1:2000
MKD8/9 Cell Signaling, Frankfurt, Germany #9252 Rabbit 1:2000
CIV DAKO, Hamburg, Germany #M0785 Mouse 1:500
MBP DAKO, Hamburg, Germany #A0623 Rabbit 1:200
MHC Leica Biosystems, Newcastle, United Kingdom,
#NCL-MHCf
Mouse 1:50
TUBA1A Cell Signaling, Frankfurt, Germany #2521 Rabbit 1:5000
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tions and had access to water and standard rodent diet (V1534, Ssniff,
Soest, Germany) ad libitum. All experiments were approved by the
Committee on Animal Health and Care of the local governmental
body of the state of Upper Bavaria (Regierung von Oberbayern) and
performed in strict compliance with the European Communities
Council Directive (86/609/EEC) recommendations for the care and
use of laboratory animals.
2.2. SHIRPA-protocol
Transgenic and control mice were examined according to a slightly
modiﬁed SHIRPA observational test [16,17].
2.3. Tissue preparation
Muscles and nerves were dissected according to their location
described in a mouse anatomic atlas [18]. Muscles were blotted dry
and weighed to the nearest milligram.
2.4. RNA expression analysis
Nerve ﬁbers were homogenized in TRIzol® (Invitrogen, Karlsruhe,
Germany) for RNA isolation and 1 μg of RNA was reverse-transcribed
in a ﬁnal volume of 35 μl using Superscript™ II Reverse Transcriptase
(Invitrogen) according to the manufacturer's instructions. For qualita-
tive mRNA expression of murine and transgenic (human) Epgn/EPGN,
RT-PCR using reagents from Qiagen (Hilden, Germany) was performed.
The ﬁnal reaction volume was 20 μl, and cycle conditions were 94 °C
for 5 min, followed by 35 cycles of 94 °C for 1 min, 60 °C for 1 min,
and 72 °C for 1 min. The primers employed were: murine Epgn
forward primer 5′-ACTACATAGAAGAACCTGTAGC-3′ and reverse
primer 5′-GCTTGATGACTATGTCTTATAAG-3′; human EPGN forward
primer 5′-TTTGGGAGTTCCAATATCAGC-3′ and reverse primer 5′-
TGTGATTGGAGGTGTTACAGTCA-3′; and Gapdh forward primer 5′-
TCATCAACGGGAAGCCCATCAC-3′ and reverse primer 5′-AGACTCCA
CGACATACTCAGCACCG-3′.
Quantitative mRNA expression analysis was performed by real-
time quantitative RT-PCR using the LightCycler® 480 System and
the LightCycler® 480 Probes Master (Roche, Mannheim, Germany).
Final primer concentration was 0.5 μM and probe concentration
was 0.2 μM. The ﬁnal reaction volume was 10 μl, and cycle condi-
tions were 95 °C for 5 min followed by 45 cycles of 95 °C for 10 s,
60 °C for 15 s, and 72 °C for 1 s. Quantitative values are obtained from
the Ct number at which the increase in the signal associated with the
exponential growth of PCR products begins to be detected. Transcript
copy numbers were normalized to Actb mRNA copies. Results are
expressed as fold differences in target gene expression relative to Actb
transcripts. The ΔCt value of the sample was determined by subtracting
the average Ct value of the target gene from the average Ct value of the
Actb gene. Probes were labeled with the reporter dye FAM at the 5′ and
the quencher dye TAMRA at the 3′ end. For each primer pair, we
performed no-template control and no-RT control assays, which
produced negligible signals that were usually greater than 40 in their
Ct value. Experiments were performed in duplicates for each sample.
Sequences of primers (Thermo Fisher Scientiﬁc, Dreieich, Germany)
and probes (Roche) for the evaluated transcripts are shown in Table 1.
2.5. Western blot analysis
For protein extraction, tissue samples were homogenized in
Laemmli-extraction-buffer, and the protein content was estimated
by the bicinchoninic acid (BCA) protein assay. 20 μg of total protein
was separated by 8% or 12% SDS-PAGE and transferred to PVDFmem-
branes (Millipore, Billerica, USA) by electroblotting. Membranes
were washed in Tris-buffered saline solution with 0.1% Tween-20(TBS-T) and blocked in 5% w/v fat-free milk powder for 1 h at room
temperature. Membranes were washed again in TBS-T and incubated
in 5% w/v BSA of the appropriate primary antibody overnight at 4 °C.
All primary antibodies are shown in Table 2. After washing, mem-
branes were incubated in 5% w/v fat-free milk powder with a horse-
radish peroxidase-labeled secondary antibody (donkey anti-rabbit;
1:2000; NA934V; GE-Healthcare, Munich, Germany or rabbit anti-
mouse; 1:2000; #7076; Cell Signaling, Frankfurt, Germany) for 1 h
at room temperature. Bound antibodies were detected using an
enhanced chemiluminescence detection reagent (ECL Advance Western
Blotting Detection Kit, GE Healthcare) and appropriate X-ray ﬁlms
(GE Healthcare). After detection, membranes were stripped by incu-
bation with an appropriate buffer (2% SDS, 62.5 mM Tris/HCl, pH 6.7
and 100 mM β-mercaptoethanol) for 40 min at 70 °C and incubated
with a second primary antibody recognizing the total protein of a
phosphorylated protein or a housekeeper protein.
Immunoprecipitation has been described elsewhere [19]. Brieﬂy,
200 μg of protein samples was incubated with 2 μg rabbit anti-EGFR
antibodies for 3 h at 4 °C in an overhead shaker. 25 μl of protein A
magnetic beads (Cell Signaling) was then added for 2 additional
hours. The immune complex was washed in PBS and resuspended in
1× Laemmli protein extraction buffer. After denaturation, the samples
were separated in an 8% SDS-PAGE and blotted to PVDF membranes
as described above. The level of receptor phosphorylation was analyzed
with antibodies shown in Table 2. Membranes were stripped and incu-
bated with an antibody recognizing the total receptor.
2.6. Histology and morphometric analysis
Muscles were ﬁxed for 24 h in fresh 4% paraformaldehyde (in PBS)
at 4 °C, dehydrated in a graded alcohol series and embedded in parafﬁn.
Parafﬁn sections were H&E-stained under standard conditions.
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Sectionswere ﬁxed in 4% paraformaldehyde in PBS for 15 min, followed
by Masson trichrome staining using a standard protocol.
Nerves were stretched on a blotting paper and immersed in 2.5%
glutaraldehyde in Soerensen's phosphate buffer (pH 7.4) for 1 h.
Soerensen's phosphate buffer was subsequently used to rinse the ﬁxed
nerve segments. Transverse segments with a length of 2 mm were cut
and post-ﬁxed in 2% OsO4 for 2 h. Repeated Soerensen's phosphate
buffer rinses and a graded alcohol series were carried out before the
segments were embedded in epoxy resin. For microscopic and
morphometric evaluations, semithin sections (0.5 μm) were mounted
on triethoxysilane-coated slides and stained with azur II–methylene
blue–safranin. For electron microscopy, ultrathin sections (80 nm)
were contrasted with uranyl acetate and lead citrate. Specimens were
assessed via Zeiss-EM10 (Germany).
Morphometric analysiswas done as described elsewhere [20]. Brieﬂy,
for muscle ﬁber and nuclei analysis every ﬁfth visual ﬁeld was evaluated
using a counting frame. Starting from a random point outside the tissue,
each section was examined as a series of vertical and horizontal parallel
stripes at 400× magniﬁcation. All muscle ﬁbers and nuclei within the
visual ﬁeld were counted, except for those touching the right-hand and
lower lines of the ﬁeld. Leica LAS software V3.8.0 (Leica Microsystems,
Heerbrugg, Switzerland) was used for area calculation.
For g-ratio analysis, four semithin sections per animal and nerve
were evaluated in the following manner: starting from a random
point outside the tissue, each section was examined as a series of verti-
cal and horizontal parallel stripes at 1000× magniﬁcation. Every third
visual ﬁeld covering nerve tissue was selected for measuring axon
area and myelin area of any myelinated ﬁber using Leica LAS software
V3.8.0. All ﬁbers in the visual ﬁeld were measured, except for those
touching the right-hand and lower lines of the ﬁeld. G-ratio was calcu-
lated by the quotient of axon area/ﬁber area.
For myelin area analysis, the blue-stained areas of six semithin sec-
tions per animal andnerveweremeasured via Leica LAS software V3.8.0.
2.7. Statistical analysis
Data are presented asmeans ± SDor box-plots withmedian (quan-
titative RT-PCR). SHIRPA data are presented asmeans ± SEM. Quantita-
tive RT-PCR values were related to the mean value of the control group
and compared by Mann–Whitney U-tests (GraphPad Prism, GraphPad
Software, San Diego, USA). The remaining data were analyzed with
Student's t-test. P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Overexpression of epigen causes a late-onset muscular atrophy
We recently reported that transgenic mice with ubiquitous
overexpression of human epigen, a poorly characterized EGFR ligandA B
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Fig. 1. Characterization of themuscular phenotype of Epigen-tgmice. (A) Enhanced limb-claspi
of spontaneous locomotor activity (crossed squares), grip strength, grid hanging time, and t
genotype). AU = arbitrary units.[21,22], show hyperproliferation of the skin and its appendages [14].
Long-term observation of Epigen-tg animals revealed symptoms of
impaired neuromuscular function, ﬁrst observable at 4–6 months of
age and including trembling and atonyof thehind limbs as demonstrated
by enhanced limb-clasping reﬂex when suspended by the tail (Fig. 1A).
A SHIRPA analysis conﬁrmed impairment in motor and proprioceptive
function (Fig. 1B). Both male and female Epigen-tg mice at different
ages showed a signiﬁcant reduction in total body weight and carcass
weight, indicating decreasedmusclemass (Supplementary Fig. 1). Eval-
uation of the absoluteweight of the tricepsmuscle revealed a signiﬁcant
reduction in Epigen-tg females as compared to control, gender-
matched littermates, but the reduction turned out to be allometric
(proportional to the change in total body weight, Supplementary
Fig. 1A). In contrast, the signiﬁcant reduction in the absolute weight of
the quadriceps muscle was maintained when expressed in relation to
total body weight (Supplementary Fig. 1A), indicating a more severe
impairment of hind limb muscles as compared to those of the front
limb (see also Supplementary Fig. 2). Since the same effect was
observed in males (Supplementary Fig. 1B) a gender-speciﬁc effect is
unlikely and further examinations were carried out in females only.
Histological analysis revealed no changes in the tissue architecture of
the triceps muscle in 2-month-old and 10-month-old Epigen-tg mice,
whereas small areas of fatty degeneration and a prominent ﬁber size
variation were observed in 18-month-old transgenic animals (Fig. 2A).
At this age, the tricepsmuscle showed several partially grouped atrophic,
angular ﬁbers and satellite cells. In contrast, satellite cells were readily
observable in the quadriceps muscle of 2-month-old Epigen-tg mice
(Fig. 2A). Furthermore, an age-dependent increase in ﬁber size variation
with augmented numbers of angular ﬁbers and internalized nuclei was
seen in the quadriceps muscle of older animals (Fig. 2A). Muscle ﬁber
hypertrophy and central nucleation are indicative of secondary myo-
pathic changes, potentially related to ongoing denervation [23]. Quanti-
tative analysis revealed a signiﬁcant increase in the density of nuclei and
a decrease in themeanﬁber area in the quadriceps but only a trend in the
triceps of 10-month-old transgenic mice (Fig. 2B). Next, to assess ﬁber
type grouping, we carried out immunohistochemistry to detect type II
myosin in the quadriceps and triceps muscles. At the age of 2 months,
type I ﬁbers were restricted to a small area at the periphery of the quad-
riceps muscle and corresponded to 1.33 ± 0.1% of ﬁbers in control and
1.14 ± 0.09% of ﬁbers in transgenic mice (P = 0.14). At the age of
10 months, a comparable number of type I ﬁbers were still visible at
the periphery of the quadriceps in control mice, whereas only type II
ﬁbers were detected in the quadriceps muscle of transgenic mice. A
similar picture was observed in the triceps muscle (data not shown).
Therefore, while ﬁber type grouping can be excluded at the age of
2 months, the loss of type I ﬁbers at the age of 10 months suggests
ﬁber grouping. Nevertheless, a classical picture of ﬁber grouping, as
would be seen in a mixed muscle, cannot be proven by immunohisto-
chemistry in Epigen-tg mice since in both control and transgenic mice
the quadriceps and triceps muscles were composed almost exclusivelyCo Tg
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data for rodents [24,25].
To exclude differences in the regional expression of the transgene
as the reason for these observations, we evaluated the presence of
transgene-derived epigen transcripts in different tissues by RT-PCR.
Transgene expression was detected in the cervical, thoracic, and lumbar
spinal cord and in the peripheral radial and femoral nerves, as well as in
the triceps and quadriceps muscles (Supplementary Fig. 3). Taken to-
gether, these ﬁndings suggest a neuronal origin of themuscular atrophy.Control Transgenic
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terized by reduced axonal diameters, ﬁnal naked axons, and severely reduced ﬁber density. O
demyelination, whereas myelin disintegration was interpreted as a processing artifact. Scale ba3.2. The muscle atrophy is due to a demyelinating neuropathy
Having established a probable neuronal origin of the muscle
atrophy, we next evaluated the presence of histological changes in the
central and peripheral nervous systems of Epigen-tg mice and control
littermates at the ages of 2, 10, or 18 months. No changes in tissue archi-
tecture could be seen in H&E-stained transversal sections of the brain
and spinal cord (data not shown). In contrast, the femoral nerve
showed a demyelinating neuropathy with a prominent reduction ofControl Transgenic
Femoral nerve
degeneration. Note the early neuropathy in the femoral nerve of transgenic mice, charac-
nly clear thinning of the myelin sheath in comparison to axon diameter was rated as real
rs indicate 20 μm.
2072 M. Dahlhoff et al. / Biochimica et Biophysica Acta 1832 (2013) 2068–2076axon diameters and signs of axon degeneration, which was already
detectable at the age of 2 months and increased in severity with
age (Fig. 3). A similar although considerably milder neuropathy could
be recognized in the radial nerve of 18-month-old transgenic animals
(Fig. 3). Quantitative analysis carried out in 10-month-old mice sup-
ported these observations, revealing signiﬁcant reductions in the
numbers of axons per nerve (Fig. 4A) and per area (Fig. 4B), in myelin
area (Fig. 4C), and in the mean axon diameter (Fig. 4D) in the femoral
nerve, but only negligible changes in the radial nerve of Epigen-tg
animals. Next, we evaluated the myelin sheath thickness by deter-
mining the g-ratio [26]. The average g-ratio in the radial nerve did not
differ between genotypes (Fig. 4E). In contrast, the g-ratio tended to
be higher in the femoral nerve of Epigen-tg mice (Fig. 4E), indicating
that their myelin sheaths were thinner as compared to those of control
animals. Electronmicroscopy revealed de- and remyelinating processes
next to naked axons and the presence of single intratubular macro-
phages (Supplementary Fig. 4) being especially pronounced in the
femoral nerve of 18-month-old Epigen-tg mice.
Next, we focused on the activity of typical signaling pathways asso-
ciated with the myelination process. Mitogen-activated protein kinase
(MAPK1/2) and AKT1 are the major signaling pathways employed by
ERBB2/3 tomodulate Schwann cell myelination [27,28], and AKT1 is es-
sential for correctmyelination in the PNS [29]. While we failed to detect
any changes in MAPK1/2 activation in the nerves of Epigen-tg mice
independently of their site, we observed a clear reduction in theA
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AKT1 activation in the femoral nerve (Fig. 5). Evaluation of other
signaling (mitogen-activated protein kinase 8/9 (MKD8/9), protein
kinase C alpha (KPCA)) or structural (E-cadherin (CADH1), N-cadherin
(CADH2), myelin protein P0 (Mpz), myelin basic protein (Mbp),
connexin-32 (Gjb1)) molecules known to regulate myelination
failed to reveal any changes in Epigen-tg mice as compared to control
animals (Supplementary Fig. 5).
Collectively, these ﬁndings indicate that the muscle atrophy in
Epigen-tg mice is a consequence of a demyelinating neuropathy.
3.3. The muscular phenotype and the neuropathy are EGFR-dependent
Western blot analysis readily revealed a stronger phosphorylation of
tyrosine residues of the EGFR in the radial and femoral nerves of Epigen-
tg mice as compared to control animals (Fig. 6A). However, since a
peripheral neuropathy similar to the phenotype of Epigen-tg mice has
not been previously described in transgenic models overexpressing
other EGFR ligands [30], we next asked whether these changes are in-
deed mediated by the EGFR. To clarify this point, we crossed Epigen-tg
mice with Wa5 animals, an ENU-derived mutant line expressing an
antimorphic EGFR [15]. The Wa5 allele completely rescued the reduc-
tion in carcass weight (Fig. 6B) as well as the absolute and relative
weight of the quadriceps muscle (Fig. 6C). Furthermore, the histological
changes of the quadriceps muscle (Fig. 6D) and of the femoral nerveFiber area (µm2)
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of theWa5 allele. These data strongly indicate that the described pheno-
type is EGFR-dependent.
3.4. Increased deposition of extracellular matrix in the nerves of Epigen-tg
mice
Since the EGFR is abundantly expressed in ﬁbroblasts [31], but
only at low levels in adult Schwann cells [32], we evaluated whether
increased activation of the EGFR in ﬁbroblasts possibly altered the
deposition of extracellular matrix proteins. As shown in Fig. 7A, a
Masson trichrome staining revealed increased levels of connective
tissue in the femoral nerve of 10-month-old Epigen-tg mice as com-
pared to control littermates. In accordance, Western blot analysis
conﬁrmed increased amounts of collagen IV in both the radial and
the femoral nerves of Epigen-tg mice as compared to control litter-
mates (Fig. 7B).
4. Discussion
Here,we report a symmetric and distally pronouncedmuscular atro-
phy of rather late onset in transgenic mice overexpressing epigen, theTriceps Quadriceps
Co
Wa5
Tg
Tg+Wa5
*
Triceps Quadriceps
*
Tg+Wa5Tg
Tg+Wa5Tg
precipitation revealed unchanged levels of total EGFR but increased EGFR phosphorylation
te and relative weight of the triceps and quadricepsmuscles (C) of Epigen-tg females after
ithin sections of the femoral nerve (E) showing no abnormalities in Epigen-tg/Wa5 double
nth-old females, *P b 0.05. The scale bars in D represent 100 μm and in E 20 μm.
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Epigen, originally identiﬁed during high throughput sequencing of a
mouse keratinocyte library [21], is expressed in several organs and is a
potent mitogen in spite of having a low afﬁnity to the EGFR [22]. Only
limited information about epigen exists, including its detection as a
protein overexpressed in human cancer specimens [33,34], its iden-
tiﬁcation as a target of LH/hCG in mouse granulosa cells [35], of
interleukin-13 in primary airway epithelial cells [36], and of
ectodysplasin in the skin [37] and mammary gland [38]. Epigen also
appears to play a role in sebaceous glands [14,39]. In contrast, among
the family of EGFR ligands, epigen was shown to play a minor role in
the pathogenesis of malignant peripheral nerve sheath tumors [40].
Mice lacking epigen develop and grow normally, probably due to
functional compensation by the remaining EGFR ligands [41].
Histological examination and molecular analysis of signaling path-
ways indicate that themuscular phenotype of Epigen-tgmice is second-
ary to PNS demyelination and axon degeneration. In a classical genetic
experiment, we also show that the phenotype is completely EGFR-
dependent. However, while the histological changes in the muscles of
Epigen-tg mice strongly suggest pathology of neuronal origin, a con-
comitant primary myopathic process cannot be fully excluded. To our
knowledge, this is the ﬁrst report of a peripheral neuropathy in associa-
tion with EGFR hyperactivation. The fact that the EGFR is not expressed
in adult Schwann cells [32] suggested that the mechanism behind the
peripheral neuropathy is possibly Schwann cell extrinsic. To explore
the possibility that the phenotype is mediated by ﬁbroblasts of the
endoneurium and perineurium, cells known to carry the EGFR [31],
we evaluated the abundance of extracellular matrix proteins. Indeed,
we could readily detect ﬁbrosis and increased levels of collagen IV in
the nerves of Epigen-tg mice.
While we cannot offer a deﬁnitive proof for ﬁbroblast-mediated
alterations of the ECM composition as the cause of the reported patholo-
gy, there are several facts supporting such a mechanism. First, although
the regulatory impact of nerve ﬁbroblasts has received little attention
so far, it is known that these cells can inﬂuence Schwann cell behavior
in different ways [42]. One of the most important functions ofCollagen IV
TUBA1A
Co    Co    Tg  
Radial nerv
A
B
Co
Fig. 7.Masson trichrome staining revealed increased levels of connective tissue in the femoral
analysis showing increased levels of collagen IV in the radial and femoral nerves of 10-month-o
were stripped and tubulin was detected as a loading control. Scale bars in A represent 50 μm.endoneurium ﬁbroblasts is the secretion of ECM, a complex network of
secreted proteins that provides mechanical support to the resident cells
and promotes axon–Schwann cell interactions [43,44]. Second,
changes in the composition of endoneurial ECM have been described
in a large number of human peripheral neuropathies [45], the
peripheral neuropathy of the twitcher mouse, a model for human
globoid leukodystrophy, is associated with massive changes in the
ECM of the endoneurium [46,47], and mice lacking basal lamina
components such as laminin α2 chain [48,49] or β1 integrin [50]
show a severe neuropathy and represent models of congenital mus-
cular dystrophy. Third, increased levels of other EGFR ligands such as
transforming growth factor-α or amphiregulin have been reported
to result in ﬁbrosis in several organs, including the lung [51,52], the
exocrine [53], and the endocrine pancreas [54].
Interestingly, the phenotype of Epigen-tg mice resembles some sub-
types of Charcot–Marie–Tooth (CMT) disease, a genetically heteroge-
neous disorder and the most common inherited neurologic disease in
humans [55]. CMT1A, the most frequent form of CMT, is caused by
increased PMP22 expression due to a chromosomal duplication at
17p11.2 [55]. Transgenic mice engineered to overexpress human [56]
or mouse [57] PMP22 show early-onset (~3 weeks of age) neurological
disorders and a shortened lifespan, dying before 5 months of age.
Notably, in at least one of these lines, PMP22 overexpression was
shown to enhance collagen synthesis byﬁbroblasts prior tomyelination
[58]. The neuropathy of Epigen-tg mice also bears some similarities to
that of periaxin-deﬁcient mice [59], a model of CMT4F.
In conclusion, we describe for the ﬁrst time a peripheral demye-
linating neuropathy as a consequence of increased EGFR activation.
Our data suggest that the pathogenic mechanism is related to increased
deposition of extracellular matrix, possibly due to the activation of
the EGFR in endoneurium ﬁbroblasts of Epigen-tg mice. Due to the
rather late onset and slow progression of the disease, we believe
that Epigen-tg mice are an appealing model for studying molecular
events associated with early stages of peripheral neuropathies, an
essential prerequisite for the development of successful therapeutic
interventions.  Tg
e
Co    Co    Tg    Tg
Femoral nerve
Tg
nerve of 10-month-old Epigen-tg mice compared to control littermates (A). Western blot
ld Epigen-tg mice compared to control littermates (B). After detection of collagen IV, blots
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